Revision about hearing loss in the Alport's syndrome, analyzing the clinical, genetic and bio-molecular aspects;Revisão sobre a perda auditiva na Síndrome de Alport, analisando os aspectos clínicos, genéticos e biomoleculares

Revista Brasileira de Otorrinolaringologia

Volumn 71, Issue 6, 2005, Pages 813-819

  Alves, Fátima R A ^a,b,c   Ribeiro, Fernando De A Quintanilha ^a  

^a FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^b Hospital do Servidor Público Municipal   (Brazil)

^c Faculdade de Ciências Médicas da Santa Casa de São Paulo ^*  (Brazil)

Author keywords

Alport's syndrome; Collagen type IV; Genetics; Hearing loss

Indexed keywords

COLLAGEN TYPE 4;

ALPORT SYNDROME; BASEMENT MEMBRANE; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE COURSE; GENETIC DISORDER; HEARING LOSS; HEMATURIA; HUMAN; KIDNEY FAILURE; MEDICAL GENETICS; MEDICAL LITERATURE; MEDICAL SPECIALIST; NONHUMAN; PERCEPTION DEAFNESS; PROGNOSIS; REVIEW; URINALYSIS;

EID: 33746803778     PISSN: 00347299     EISSN: 00347299     Source Type: Journal    
DOI: 10.1590/s0034-72992005000600020     Document Type: Review

References (25)

1. Gleeson MJ. Alport's syndrome: audiological manifestations and implications. J Laryngol Otol 1984; 98(5): 449-65.
2. Alport AC. Hereditary familial congenital hemorrhagic nephritis. Br Med J 1927; 1: 504-6.
3. Kashtan CE, Michael AF. Alport syndrome. Kidney Int 1996; 50(5): 1445-63.
4. Barker DF, Pruchno CJ, Jiang X, Atkin CL, Stone EM, Denison JC, et al. A mutation causing Alport syndrome with tardive hearing loss is common in the Western United States. Am J Hum Genet 1996; 58(6): 1157-65.
5. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Mechanisms of the disease: Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 2003; 348: 2543-56.
6. Atkin CL, Gregory MC, Border WA. Alport syndrome. In: Schrier RW, Gottschalk CW. Diseases of the kidney. 4thed., Boston: Little, Brown, 1988. p.617-41.
7. Wester DC, Atkin CL, Gregory MC. Alport syndrome: clinical update. J Am Acad Audiol 1995; 6(1): 73-9.
8. Gross O, Netzer KO, Lambrecht R, Seibold S, Weber M. Meta-analysis of genotype-phenotype correlation in X- linked Alport syndrome: impact on clinical counseling. Nephrol Dial Transplant 2002; 17(7): 1218-27.
9. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, Gerken SC, et al. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 1990; 248: 1224-7.
10. Kalluri R. Basement membranes: structure, assembly and role in tumor angiogenesis. Nat Rev Cancer 2003; 3(6): 422-33.
11. Pirson Y. Making the diagnosis of Alport's syndrome. Kidney Int 1999; 56(2): 760-75.
12. Flinter FA, Cameron JS, Chantler C, Houston I, Bobrow M. Genetics of classic Alport's syndrome. Lancet 1988; 2: 1005-7.
13. Cassady G, Brown K, Cohen M, DeMaria W. Hereditary renal dysfunction and deafness. Pediatrics 1965; 35: 967-79.
14. Rintelmann FW. Auditory manifestations of Alport's disease syndrome. Tr Am Acad Ophth Otol 1976; 82: 375-87.
15. Cosgrove D, Samuelson G, Pinnt J. Immunohistochemical localization of basement membrane collagens and associated proteins in the murine cochlea. Hear Res 1996; 97: 54-65.
16. Cosgrove D, Kornak JM, Samuelson G. Expression of basement membrane type IV collagen chains during postnatal development in the murine cochlea. Hear Res 1996; 100: 21-32.
17. a VH, Hudson BG. Identification and localization of type IV collagen chains in the inner ear cochlea. Connect Tissue Res 1998; 37: 143-50.
18. Cosgrove D, Samuelson G, Meehan DT, Miller C, McGee J, Walsh EJ, et al. Ultrastructural, physiological, and molecular defects in the inner ear of a gene-knockout mouse model for autosomal Alport syndrome. Hear Res 1998; 121: 84-98.
19. Harvey SJ, Mount R, Sado Y, Naito I, Ninomiya Y, Harrison R, et al. The inner ear of dogs with X-linked nephritis provides clues to the pathogenesis of hearing loss in X-linked Alport syndrome. Am J Pathol 2001; 159(3): 1097-104.
20. Sirimanna KS, France E, Stephens, SDG. Alport's syndrome: can carriers be identified by audiometry? Clin Otolaryngol 1995; 20: 158-63.
21. McDonald TJ, Zincke H, Anderson CF, Ott NT. Reversal of deafness after renal transplantation in Alport's Syndrome. Laryngoscope 1978; 88: 38-42.
22. Avraham KB. Mouse models for deafness: lessons for the human inner ear and hearing loss. Ear Hear 2003; 24(4): 332-41.
23. Sefer S, Trotic R, Lacmanovic V, Degoricia V, Ratkovic-Gusic I, Kes P. Effects of renal transplantation on hearing and ocular changes in a monozygotic twin with Alport's syndrome: comparison with other twin on hemodialysis. Croat Med J 2000; 41(2): 203-6.
24. Harvey SJ, Zheng K, Jefferson B, Moak P, Sado Y, Naito I, et al. Transfer of the α5(IV) collagen chain gene to smooth muscle restores in vivo expression of the α6(IV) collagen chain in a canine model of Alport syndrome. Am J Pathol 2003; 162(3): 873-85.
25. Lalwani AK, Mhatre AN. Cochlear gene therapy. Ear Hear 2003; 24(4): 342-8.